GlobalData
GlobalData

Pharma

Commercial prospects for immuno-oncology development across oncology indications in untapped cancer types or in combinations, says GlobalData

Immuno-Oncology (IO) development is booming across the 8MM*, with IO agents being investigated in most cancer types, in combination or alone, representing a huge commercial opportunity for established players and novel developers alike, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Immuno-oncology Development Trends and Opportunities’ combines research with a global, cross-specialty […]
Read more

APAC drug delivery devices market to reach $5.4 billion in 2023

Asia Pacific (APAC) region contributed 21% of global revenue in 2016 and the region is expected to witness higher growth compared to other regions. The company’s latest reveals that Japan will emerge as the major country in APAC region contributing 64% of the revenue in 2023. Japan contributed 62% of the revenue in the region […]
Read more
1 107 108 109